Lung Cancer
Autor Stephen Falk, Chris Williamsen Limba Engleză Paperback – 14 oct 2009
Preț: 71.01 lei
Preț vechi: 81.13 lei
-12% Nou
Puncte Express: 107
Preț estimativ în valută:
13.59€ • 14.81$ • 11.40£
13.59€ • 14.81$ • 11.40£
Carte tipărită la comandă
Livrare economică 09-14 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780199569335
ISBN-10: 0199569339
Pagini: 168
Ilustrații: Various 2-colour line drawings and black and white halftones
Dimensiuni: 128 x 196 x 9 mm
Greutate: 0.16 kg
Ediția:3 Rev ed.
Editura: Oxford University Press
Colecția OUP Oxford
Locul publicării:Oxford, United Kingdom
ISBN-10: 0199569339
Pagini: 168
Ilustrații: Various 2-colour line drawings and black and white halftones
Dimensiuni: 128 x 196 x 9 mm
Greutate: 0.16 kg
Ediția:3 Rev ed.
Editura: Oxford University Press
Colecția OUP Oxford
Locul publicării:Oxford, United Kingdom
Recenzii
...this is a comprehensive book that I would recommend for patients, lay carers and professionals who wish to get information on lung cancer.
...a great resource for someone who is newly diagnosed with lung cancer and a great help for the practitioner.
I have reviewed quite a few books about lung cancer this is one of the best so far. Everything is explained really well for carers and it will help them to understand the mental strain on the patient. I like the honest content, the hope for the future and the explanation of the whole process, from symptoms, through diagnosis to treatment options. The introduction is excellent; it made me want to obtain more knowledge.
This is a no-nonsense, practical, factual book on all aspects of lung cancer; it will be useful for anyone affected by cancer who is trying to understand what is happening and why. It is very clear and easy to understand; the authors use plain English, which would appeal to anyone with no medical knowledge.
As a prospective undergraduate medical student with a strong interest in oncology, I found this resource incredibly informative. It has an abundance of information about the treatment of lung cancer, giving a patient (or anyone involved in their care) an accurate picture of what he/she can expect, thus slightly alleviating possible anxieties. It is also a very good quick reference resource for professionals.
...a great resource for someone who is newly diagnosed with lung cancer and a great help for the practitioner.
I have reviewed quite a few books about lung cancer this is one of the best so far. Everything is explained really well for carers and it will help them to understand the mental strain on the patient. I like the honest content, the hope for the future and the explanation of the whole process, from symptoms, through diagnosis to treatment options. The introduction is excellent; it made me want to obtain more knowledge.
This is a no-nonsense, practical, factual book on all aspects of lung cancer; it will be useful for anyone affected by cancer who is trying to understand what is happening and why. It is very clear and easy to understand; the authors use plain English, which would appeal to anyone with no medical knowledge.
As a prospective undergraduate medical student with a strong interest in oncology, I found this resource incredibly informative. It has an abundance of information about the treatment of lung cancer, giving a patient (or anyone involved in their care) an accurate picture of what he/she can expect, thus slightly alleviating possible anxieties. It is also a very good quick reference resource for professionals.
Notă biografică
Stephen Falk is a consultant clinical oncologist based in Bristol with sessional commitments to Yeovil. Major clinical interests are thoracic and gastro-intestinal malignancies. Interest in research was stimulated as a MRC Clinical Scientist in Norman Bleehens' unit in Cambridge where the MRC cancer trials unit was situated at the time. A MD related to lung cancer and scheduling of topoisomerase poisons with and without radiation is the basis of an on-going interest in chemo-radiation interactions. He is lead doctor for Clinical Oncology in Bristol and clinical lead for research and development within the Bristol Haematology and Oncology centre and for the National Cancer Research Network locally in Avon Somerset and Wiltshire. He is also a member of the NCRI upper GI studies committees. Increasing research management activity is reflected in his current role as co-clinical director of the UK comprehensive local research network western.